AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,163 Cr | ₹1,809 Cr | ₹867 Cr | ₹903 Cr | ₹807 Cr |
What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1,163 Cr |
| Mar2024 | ₹1,809 Cr |
| Mar2023 | ₹867 Cr |
| Mar2022 | ₹903 Cr |
| Mar2021 | ₹807 Cr |
How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,163 Cr | -35.72 | |
| Mar2024 | ₹1,809 Cr | 108.67 | |
| Mar2023 | ₹867 Cr | -4.01 | |
| Mar2022 | ₹903 Cr | 11.87 | |
| Mar2021 | ₹807 Cr | - | |
Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹80,504.7 Cr | 3.5% | 5.5% | 25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.5% |
5.5% |
25.4% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses